Ranbaxy sues U.S. FDA over revoking approvals for Nexium, Valcyte copies

Ranbaxy Laboratories Ltd has sued the U.S. Food and Drug Administration (FDA) for revoking approvals granted to the Indian firm to launch copies of two drugs including AstraZeneca Plc's heartburn pill Nexium, court documents showed.

http://in.reuters.com/article/2014/11/18/ranbaxy-lab-fda-lawsuit-idINL3N0T830P20141118

YOU ARE BEING REDIRECTED TO THE ARTICLE
. . .
× CLOSE

PROCESSING